Evidence map›Paper›PMID 36305111›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2022

[A 10-year retrospective study of pathogens and antimicrobial resistance in neonatal sepsis].

Yuan-Qiang Yu, Qing-Yi Dong, Jin-Tao Hu, Wen Li, Tao Wang, Yong-Hui Yang, Xiao-Yun Gong, Xiao-Ri He, Ping-Yang Chen

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuan-Qiang YuDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Qing-Yi DongDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Jin-Tao HuDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Wen LiDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Tao WangDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Yong-Hui YangDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Xiao-Yun GongDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Xiao-Ri HeDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Ping-Yang ChenDepartment of Neonatology, Children's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the changes in the pathogen spectrum and antimicrobial resistance over time in neonatal sepsis.

methodsThe medical data were collected from the neonates who were diagnosed with sepsis in the Second Xiangya Hospital of Central South University from January 2010 to December 2019. The incidence rate of sepsis, the pathogen spectrum, and the characteristics of antimicrobial resistance were analyzed.

resultsThe incidence rate of neonatal sepsis was 4.02% (447/11 111). The top four pathogens detected were coagulase-negative staphylococci (CoNS),

conclusionsThe incidence of neonatal sepsis is high, and the main pathogen is CoNS. The pathogens of neonatal sepsis have a high resistance rate to penicillins and third-generation cephalosporins. It is recommended to enhance the prevention and control of neonatal infection, strengthen the surveillance of pathogens, and further standardize the rational use of antibiotics.

Indexed as

Neonatal SepsisSepsisAnti-Bacterial AgentsCephalosporinsDrug Resistance, BacterialEscherichia coliHumansInfantInfant, NewbornInfant, PrematureMicrobial Sensitivity TestsPenicillinsRetrospective StudiesAnti-Bacterial AgentsCephalosporinsPenicillinsAntimicrobial resistanceIncidenceNeonatal sepsisNeonatePathogen

Identifiers

PMID36305111
PMCPMC9627997
OpenAlexW4307773752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.